- Home
- KPLT vs RVPH Comparison
KPLT vs RVPH Comparison
Compare KPLT & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPLT
- RVPH
- Stock Information
- Founded
- KPLT 2012
- RVPH 2006
- Country
- KPLT United States
- RVPH United States
- Employees
- KPLT N/A
- RVPH N/A
- Industry
- KPLT Diversified Commercial Services
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- KPLT Consumer Discretionary
- RVPH Health Care
- Exchange
- KPLT Nasdaq
- RVPH Nasdaq
- Market Cap
- KPLT 35.6M
- RVPH 32.8M
- IPO Year
- KPLT N/A
- RVPH N/A
- Fundamental
- Price
- KPLT N/A
- RVPH $0.37
- Analyst Decision
- KPLT Hold
- RVPH Strong Buy
- Analyst Count
- KPLT 2
- RVPH 5
- Target Price
- KPLT $12.00
- RVPH $9.00
- AVG Volume (30 Days)
- KPLT 26.3K
- RVPH 2.6M
- Earning Date
- KPLT 08-13-2025
- RVPH 08-13-2025
- Dividend Yield
- KPLT N/A
- RVPH N/A
- EPS Growth
- KPLT N/A
- RVPH N/A
- EPS
- KPLT N/A
- RVPH N/A
- Revenue
- KPLT $254,079,000.00
- RVPH N/A
- Revenue This Year
- KPLT $22.26
- RVPH N/A
- Revenue Next Year
- KPLT $11.03
- RVPH N/A
- P/E Ratio
- KPLT N/A
- RVPH N/A
- Revenue Growth
- KPLT 9.72
- RVPH N/A
- 52 Week Low
- KPLT $5.08
- RVPH $0.30
- 52 Week High
- KPLT $21.88
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- KPLT 44.48
- RVPH 30.28
- Support Level
- KPLT $7.37
- RVPH $0.35
- Resistance Level
- KPLT $8.44
- RVPH $0.83
- Average True Range (ATR)
- KPLT 0.77
- RVPH 0.07
- MACD
- KPLT -0.06
- RVPH -0.04
- Stochastic Oscillator
- KPLT 21.86
- RVPH 11.32
About KPLT Katapult Holdings Inc.
Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.